David Ramsay, a former UCSF senior vice chancellor and president of the University of Maryland, Baltimore (UMB) who since 2010 had served as associate director of the UCSF Institute for Neurodegenerative Diseases (IND), died June 18, 2020, after a short illness. He was 81.

Two innovative UCSF projects in hydrogel therapies to develop new salivary glands and restore muscle loss after facial injuries have received critical funding to move closer to clinical trials.

Among a group of 40 health care professionals observed by the study authors, those without masks touched their faces nearly four times as often as those who wore masks, indicating that masks not only are an effective barrier to disease transmission, but also may reduce face-touching, at least among health care professionals.

The researchers determined "medical vulnerability" by referencing indicators identified by the CDC, including heart conditions, diabetes, current asthma, immune conditions (such as lupus, gout, rheumatoid arthritis), liver conditions, obesity and smoking within the previous 30 days. Additionally, the researchers added e-cigarettes to tobacco and cigar use.

As the COVID-19 spreads through America’s overcrowded jails and prisons, researchers with Amend at UCSF are cautioning against using punitive solitary confinement to medically isolate infected people.

Goldstein will replace Maureen Brodie, MA, CO-OP, who is retiring. The UCSF Office of the Ombuds provides alternative dispute resolution services for all members of the UCSF community, including faculty, staff, administrators, students, post-doctoral fellows and other trainees.

UCSF has awarded UCSF Medals to three national leaders, all of whom have advanced diversity and inclusion, including through mentorship that has helped to place more underrepresented voices in the sciences.

Scientists have identified key chemical building blocks for an eventual antiviral drug against SARS-CoV-2, the virus that causes COVID-19.

The University of California Board of Regents announced the appointment of Michael V. Drake, M.D., as the 21st president of UC’s world-renowned system.